Bionect (etanercept): A Patient-Friendly Guide
Bionect is a prescription injectable medicine containing etanercept, a biologic that blocks a protein called TNF and reduces inflammation. It is used for certain autoimmune conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, severe plaque psoriasis, and some cases of juvenile idiopathic arthritis.
Bionect can help control symptoms of several inflammatory conditions, but it may also increase the risk of serious infections. Use it only as prescribed, and consult your doctor or pharmacist about your specific treatment plan.
Key facts at a glance
- RxNorm
- 607707
- Generic
- Bionect
- Class
- brand-name
- Brands
- —
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- —
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed September 3, 2026. · Read our editorial policy